
In today’s briefing:
- Block Deal Sale of About 278 Billion Won of Samsung Electronics by Samsung Life and Samsung F&M
- Furukawa (5715 JP) – Third Capital Policy Change in a Year Means Big Buyback
- HKBN (1310 HK): A Press Report Causes Trepidation
- Paragon REIT (PGNREIT SP): Cuscaden Peak’s Attractive Privatisation Offer
- EQD | Commonwealth Bank (CBA AU) – Expected Move on Profit Announcement and Option Insights
- Taiwan Top 50 ETF Rebalance Preview: Eva Air (2618 TT) Winging Its Way In
- Industrivärden’s FY 2024: NAV Evolution, Discount, Target NAV, Replication
- Carlyle/SNP Schneider-Neureither & Partner Ag: Trading Above Offer Price

Block Deal Sale of About 278 Billion Won of Samsung Electronics by Samsung Life and Samsung F&M
- Samsung Life Insurance (032830 KS) and Samsung Fire & Marine Insurance (000810 KS) plan to sell about 278 billion won of Samsung Electronics (005930 KS) in block deal sales.
- A total of 5 million shares of Samsung Electronics shares that are expected to be sold in this block deal sale represents 0.1% of Samsung Electronics’ outstanding shares.
- If Samsung Life Insurance is able to sell 4.256 million shares of Samsung Electronics for 236.4 billion won, this would represent 1.3% of Samsung Life Insurance’s market cap.
Furukawa (5715 JP) – Third Capital Policy Change in a Year Means Big Buyback
- In May 2023, Furukawa Co Ltd (5715 JP) decided it would review cross-holdings as part of its Actions to Implement Management Awareness of Capital Cost and Share Price.
- In February 2024, it announced a cross-holding reduction policy, and then accelerated it in May 2024. They’ve been selling. They did a small buyback too.
- Monday they announced a LARGE buyback (looks larger than it is) leaving future capital allocation policy better, but still wanting. The question is now the forward-forward bet.
HKBN (1310 HK): A Press Report Causes Trepidation
- HKBN Ltd (1310 HK) shares declined 4.4% after a Sing Tao Daily article claimed that the precondition satisfaction of China Mobile (941 HK)’s offer is at a stalemate.
- The mainland regulatory authorities have not provided any feedback on the approval process. The China Traditional Chinese Medicine (570 HK) deal break is cited as a cautionary tale.
- While the China TCM deal break taught us that no deal is safe, even an SOE-sponsored deal, the article’s concerns have little merit. This is a buy.
Paragon REIT (PGNREIT SP): Cuscaden Peak’s Attractive Privatisation Offer
- Paragon REIT (PGNREIT SP) announced a privatisation proposal from Cuscaden Peak at S$1.0033 per unit (S$0.98 cash per unit and the 2H FY2024 distribution of S$0.0233 per unit).
- The offer price is attractive compared to historical trading ranges, peer multiples and precedent privatisations. It represents an all-time high.
- No disinterested shareholder holds a blocking stake. At the current price and for an end-of-May payment, the gross/annualised spread was 1.3%/4.6%.
EQD | Commonwealth Bank (CBA AU) – Expected Move on Profit Announcement and Option Insights
- Commonwealth Bank of Australia (CBA AU) is set to announce its 2025 Half Year Results on 12 February.
- Option prices suggest a 2.4% move in either direction, which is less than the historic move of 3.4% over the past six announcements.
- Traders can trade the event through 13 February 2025 listed options (weekly expiration).
Taiwan Top 50 ETF Rebalance Preview: Eva Air (2618 TT) Winging Its Way In
- Eva Airways (2618 TT) is forecast to be added to the Yuanta/P-Shares Taiwan Top 50 ETF in March, replacing Formosa Chemicals & Fibre (1326 TT).
- Passive trackers will have 1 day of ADV to buy in Eva Airways (2618 TT) and over 3 days of ADV to sell in Formosa Chemicals & Fibre (1326 TT).
- Positioning on Eva Airways (2618 TT) does not appear excessive while Formosa Chemicals & Fibre (1326 TT) seems to be oversold.
Industrivärden’s FY 2024: NAV Evolution, Discount, Target NAV, Replication
- NAV of Industrivarden (INDUC SS) was c. SEK 160 bn (SEK 370/share) on December 31. NAV increased by 6% during FY 2024. 5-Y total return 78% (OMX30, 64%).
- Industrivärden C shares are trading at a 3.9% discount to NAV (vs. 7.4% average for last 5-years). It seems risky to bet on a further discount reduction, rather a reversal.
- My target NAV is SEK 171 bn. My TP for the C shares of Industrivärden, assuming a 5% discount to NAV, is SEK 376.5 (4.5% downside).
Carlyle/SNP Schneider-Neureither & Partner Ag: Trading Above Offer Price
- Carlyle has secured 76.3% of SNP’s voting rights and intends to delist the company, leaving minority shareholders with an illiquid stock if they do not tender their shares.
- The €61.00 offer price represents a 5.2% premium to the DCF-based fair value of €57.96, and shares currently trade at €66.20, likely due to speculative expectations of a higher bid.
- Investors should tender shares before the March 7, 2025 deadline, as post-delisting liquidity risks outweigh the uncertain potential for an improved offer. Short if there is enough available to borrow.